A detailed history of Jefferies Financial Group Inc. transactions in Geron Corp stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 9,696,535 shares of GERN stock, worth $38.7 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
9,696,535
Previous 20,030,000 51.59%
Holding current value
$38.7 Million
Previous $84.9 Million 48.16%
% of portfolio
0.33%
Previous 0.96%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.17 - $4.99 $43.1 Million - $51.6 Million
-10,333,465 Reduced 51.59%
9,696,535 $44 Million
Q2 2024

Aug 13, 2024

BUY
$3.1 - $5.09 $61.5 Million - $101 Million
19,846,609 Added 10822.02%
20,030,000 $84.9 Million
Q4 2023

Feb 13, 2024

SELL
$1.74 - $2.31 $123,729 - $164,261
-71,109 Reduced 27.94%
183,391 $386,000
Q2 2023

Aug 14, 2023

BUY
$1.97 - $3.69 $501,365 - $939,105
254,500 New
254,500 $816,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.